Lipid-coated mesoporous silica nanoparticles for anti-viral applications via delivery of CRISPR-Cas9 ribonucleoproteins

Emerging and re-emerging viral pathogens present a unique challenge for anti-viral therapeutic development. Anti-viral approaches with high flexibility and rapid production times are essential for combating these high-pandemic risk viruses. CRISPR-Cas technologies have been extensively repurposed to...

Descripción completa

Detalles Bibliográficos
Autores principales: LaBauve, Annette E., Saada, Edwin A., Jones, Iris K. A., Mosesso, Richard, Noureddine, Achraf, Techel, Jessica, Gomez, Andrew, Collette, Nicole, Sherman, Michael B., Serda, Rita E., Butler, Kimberly S., Brinker, C. Jeffery, Schoeniger, Joseph S., Sasaki, Darryl, Negrete, Oscar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133914/
https://www.ncbi.nlm.nih.gov/pubmed/37105997
http://dx.doi.org/10.1038/s41598-023-33092-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133914/
https://www.ncbi.nlm.nih.gov/pubmed/37105997
http://dx.doi.org/10.1038/s41598-023-33092-4

Ejemplares similares